Viridian Therapeutics, Inc. (VRDN): Depreciation & Amortization
$460.0K
Year ended 2025-12-31
$468.0K
Trailing 12 months to 2026-06-30
+21.7%
3-year compound annual growth
+14.0%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $460.0K | -14.8% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $540.0K | +3.4% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $522.0K | +104.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $255.0K | +112.5% | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | $120.0K | -49.8% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $239.0K | -17.0% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $288.0K | +2.5% | 2021-03-26, From 2019-01-01 |
| 2018-12-31 | $281.0K | -8.8% | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | $308.0K | -9.7% | 2019-03-14, From 2017-01-01 |
| 2016-12-31 | $341.0K | n/c | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | $184.0K | +27.8% | 2017-03-24, From 2015-01-01 |
| 2014-12-31 | $144.0K | -2.7% | 2016-03-21, From 2014-01-01 |
| 2013-12-31 | $148.0K | n/a | 2015-03-27, From 2013-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $460.0K | -14.8% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $129.0K | 0.0% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $2.19M | +0.6% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $6.42M | -10.5% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $0 | -100.0% |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $4.59M | +96.3% |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | $1.74M | +154.6% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $4.04M | +252.9% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $3.02M | -14.6% |
Compare VRDN, ASMB, RMTI, BCYC side by side · Screen every company in Pharmaceutical Preparations ↗